Skip to main content
. 2021 Jun 9;20:115. doi: 10.1186/s12934-021-01605-3

Fig. 5.

Fig. 5

In vivo bioactivity of rhIL-15, IL-15/SuIL-15Rα-dFc and IL-15/SuIL-15Rα-mFc. C57BL/6 J mice (male, 6–8 weeks of age, n = 10–14 for each group) were intravenously injected with PBS, 0.28 mg/kg rhIL-15 or 1 mg/kg IL-15/SuIL-15Rα-IgG4 Fc complexes. Seventy-two hours after treatment, spleens and blood samples were collected and prepared for flow cytometry. a Representative photo of spleens separated from each group (n = 5). b Spleen weight statistics. c The percentage of each indicated cell subset in splenocytes. d The percentage of each indicated cell subset in peripheral blood cells. The data shown in b, c, and d are combined from three independent experiments, and all data points are the means ± standard deviation. ns, not significant; *: p < 0.05; **: p < 0.01; ***: p < 0.001 and ****: p < 0.0001